Price Alert

Radiopharm Theranostics L... (RADX)

NASDAQ: RADX · Real-Time Price · USD

6.56

1.54 (30.68%)

At close: Aug 20, 2025, 1:29 PM

Radiopharm Theranostics Cash Flow Statement

Financials in AUD. Fiscal year is July - June.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Net Income	n/a	n/a	n/a
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a
Other Non-Cash Items	n/a	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a
Operating Cash Flow	n/a	n/a	n/a
Capital Expenditures	n/a	-1.53M	-28.34M
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	-1.49M	-28.37M
Investing Cash Flow	n/a	-1.53M	-28.37M
Debt Repayment	2.2M	n/a	-59K
Common Stock Repurchased	-1.53M	-854.76K	-4.83M
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	-437K	n/a	n/a
Financial Cash Flow	29.88M	9.22M	65.11M
Net Cash Flow	6.88M	-15.28M	26.95M
Free Cash Flow	-22.98M	-24.73M	-38.25M